NCT01309854View on ClinicalTrials.gov

Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Rheumatoid ArthritisHealthy VolunteersPharmacokineticsPioglitazoneDrug-drug InteractionAmount of Pioglitazone in Blood
Interventions
DRUG

fostamatinib

oral tablets, 100mg (2 X 50mg) twice daily for 8 days

DRUG

pioglitazone

oral tablets, 30mg single dose per period

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY